Tata Elxsi Share Price in Focus Ahead of Q2 FY26 Results

Tata Elxsi share price is in focus on October 9, 2025, ahead of its Q2 FY26 results announcement. Investors are looking forward to the company’s financial performance disclosure scheduled at 8:00 p.m. IST.

On October 9, 2025, Tata Elxsi share price (NSE: TATAELXSI) opened at ₹5,460.00, the same as its previous close of ₹5,460.00. At 10:17 AM, the share price of Tata Elxsi was trading at ₹5,511.50, up by 0.94% on the NSE.

Q1 FY26 Financial Highlights

For Q1 FY26, Tata Elxsi’s revenue from operations stood at ₹892.1 crore, while EBITDA reached ₹186.7 crore with a margin of 20.9%. Profit Before Tax (PBT) was ₹196.3 crore, with a PBT margin of 21.1%, and Profit After Tax (PAT) rose to ₹144.4 crore, delivering a PAT margin of 15.5%.

Inauguration of Bayer Development Centre in Radiology 

Meanwhile, looking at the latest developments, on September 10, 2025, Tata Elxsi inaugurated the Bayer Development Centre in Radiology at its Pune facility. This centre aims to co-develop advanced radiology devices with Bayer, focusing initially on Molecular Imaging. The facility integrates design, development, and validation to accelerate time-to-market, optimise costs, and ensure regulatory compliance. It will enhance Tata Elxsi’s capability to deliver innovative, safe, and efficient radiology solutions globally.

Also Read: Tata Elxsi and Infineon Team Up to Drive EV Innovation!

Conclusion

Tata Elxsi’s Q1 financials, coupled with strategic initiatives like the Bayer Radiology Centre, underscore the company’s commitment to innovation, operational excellence, and shareholder value. The stock’s positive movement reflects growing investor confidence ahead of results.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.